ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX · Real-Time Price · USD
1.560
-0.020 (-1.27%)
At close: Apr 1, 2025, 4:00 PM
1.581
+0.021 (1.35%)
After-hours: Apr 1, 2025, 5:59 PM EDT
ESSA Pharma Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for ESSA Pharma stock has a target of 2.00, which predicts an increase of 28.21% from the current stock price of 1.56.
Analyst Consensus: Hold
* Price targets were last updated on Nov 4, 2024.
Analyst Ratings
The average analyst rating for ESSA Pharma stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $15 → $2 | Buy → Hold | Downgrades | $15 → $2 | +28.21% | Nov 4, 2024 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 4, 2024 |
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 1, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $17 | Buy | Maintains | $17 | +989.74% | May 16, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $17 | Buy | Reiterates | $17 | +989.74% | Dec 13, 2023 |
Financial Forecast
Revenue This Year
n/a
from 247.82M
Revenue Next Year
n/a
EPS This Year
-0.49
from -0.64
EPS Next Year
-0.17
from -0.49
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 23.4M | 183.1M | ||
| Avg | n/a | 22.7M | 177.9M | ||
| Low | n/a | 21.8M | 170.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 706.0% | ||
| Avg | - | - | 683.0% | ||
| Low | - | - | 652.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.33 | 0.17 | 3.18 | ||
| Avg | -0.49 | -0.17 | 0.81 | ||
| Low | -0.65 | -0.48 | -0.48 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.